Down-regulation of metallothionein expression in human and murine hepatocellular tumors: Association with the tumor-necrotizing and antineoplastic effects of cadmium in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 1026-1033

  Waalkes, Michael P ^a   Diwan, Bhalchandra A ^b   Rehm, Sabine ^a   Ward, Jerrold M ^a   Moussa, Madeleine ^c   Cherian, M George ^c   Goyer, Robert A ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; CADMIUM; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; DOWN-REGULATION; HUMANS; LIVER NEOPLASMS; MALE; METALLOTHIONEIN; MICE; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030439219     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. BAKKA, A., ENDERSEN, L., JOHNSEN, A. B. S., EDMINSON, P. D. AND RUGSTAD, H. E.: Resistance against cis-diamminedichloroplatinum in cultured cells with a high content of metallothionein. Toxicol. Appl. Pharmacol. 61: 215-226, 1981
2. BANERJEE, D., ONOSAKA, S. AND CHERIAN, M. G.: Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 24: 95-105, 1982.
3. CHERIAN, M. G., HUANG, P. C., KLAASSEN, C. D., LIU, Y.-P., LONGFELLOW, D. G. AND WAALKES, M. P.: Meeting report: National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res. 53: 922-925, 1993.
4. CHERIAN, M. G., HOWELL, S. B., IMURA, N., KLAASSEN, C. D., KOROPATNICK, J., LAZO, J. S. AND WAALKES, M. P.: Role of metallothionein in carcinogenesis. Toxicol. Appl. Pharmacol. 126: 1-5, 1994.
5. COOGAN, T. P., BARE, R. M. AND WAALKES, M. P.: Increased susceptibility of spontaneously transformed cultured liver cells to cadmium induced cytotoxicity but not genotoxicity. The Toxicologist 12: 144, 1992.
6. DIWAN, B. A., RICE, J. M. AND WARD J. M.: Tumor-promoting activity of benzodiazepine tranquilizers, diazepam and oxazepam, in mouse liver. Carcinogenesis 7: 789-794, 1986.
7. DIWAN, B. A., ANDERSON, L. M., REHM, S. AND RICE, J. M.: Transplacental carcinogenicity of cisplatin: initiation of skin tumors and induction of other preneoplastic and neoplastic lesions in SENCAR mice. Cancer Res. 53: 3874-3876, 1993.
8. DIWAN, B. A., ANDERSON, L. M., WARD, J. M., HENNEMAN, J. R. AND RICE, J. M.: Transplacental carcinogenesis by cisplatin in F344/NCr rats: Promotion of kidney tumors by postnatal administration of sodium barbital. Toxicol. Appl. Pharmacol., 123: 115-121, 1995.
9. DUDLEY, R. E., SVOBODA, D. J. AND KLAASSEN, C. D.: Acute exposure to cadmium causes severe liver injury in rats. Toxicol. Appl. Pharmacol. 65: 302-313, 1982.
10. FRITH, C. H. AND WARD, J. M.: A morphologic classification of proliferative hepatic lesions in mice. J. Environ. Pathol. Toxicol. 3: 329-351, 1979.
11. GOERING, P. L. AND KLAASSEN, C D.: Zinc-induced tolerance to cadmium hepatotoxicity Toxicol. Appl. Pharmacol. 74: 299-307, 1984a.
12. GOERING, P. L. AND KLAASSEN, C. D.: Resistance to cadmium-induced hepatotoxicity in immature rats. Toxicol. Appl. Pharmacol 74: 321-329, 1984b.
13. GOERING, P. L. AND KLAASSEN, C. D.: Tolerance to cadmium-induced toxicity depends on presynthesized metallothionein in liver. J. Toxicol. Environ Health 14: 803-812, 1984c.
14. GRAY, I , ARRIEH, M. AND BALTER, N. J.: Cadmium modification of response in BALB/c mice to MOPC-104E tumor. Arch. Environ. Health 37: 342-345, 1982.
15. HENNINGS, H., SHORES, R. A., POIRIER, M. C., REED, E , TARONE, R. E. AND YUSPA, S H.: Enhanced malignant conversion of benign mouse skin tumors by cisplatin. J. Natl. Cancer Inst. 82: 836-840, 1990.
16. HENRY, R. B., LIU, J., CHOUDHURI, S. AND KLAASSEN, C. D.. Species variation in hepatic metallothionein. Toxicol. Lett. 74: 23-33, 1994.
17. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC) MONOGRAPHS: Supplement 7, Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42, pp. 67, 137-139, 170-171, 182-184, 239-240, Lyon, IARC, 1987.
18. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER MONOGRAPHS: Volume 58: Beryllium, cadmium, mercury and exposures in the glass industry, pp. 119-238, Lyon, IARC, 1993.
19. KASAHARA, K., FUJIWARA, Y., NISHIO, K., OHMORI, T., SUGIMOTO, Y., KOMIYA, K., MATSUDA, T. AND SAIJO, N.: Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin Cancer Res. 51: 3237-3242, 1991
20. KAYAMA, F., YOSHIDA, T., ELWELL, M. R. AND LUSTER, M. I.: Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 131: 224-234, 1995.
21. KELLEY, S. L , BASU, A., TEICHER, B. A., HACKER, M. P., HAMER, D. H. AND LAZO, J. S.: Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815, 1988.
22. KERKVLIET, N. I., KOLLER, L. D., BAECHER, L. G. AND BRAUNER, J. A.: Effect of cadmium exposure on primary tumor growth and cell-mediated cytotoxicity in mice bearing MSB sarcomas. J. Natl. Cancer Inst. 63: 479-483, 1979.
23. KLAASSEN, C. D.: Pharmacokinetics in metal toxicology. Fund. Appl. Toxicol. 1: 353-357, 1981.
24. KONDO, Y., KUO, S.-M. AND LAZO, J. S : Interleukin-1β-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum. J. Pharmacol. Exp. Ther. 270: 1313-1318, 1994.
25. KONDO, Y., WOO, E. S., MICHALASKA, A. E., CHOO, K. H. A. AND KAZO, J. S.: Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res. 55: 2021-2023, 1995.
26. KUROKAWA, Y., MATSUSHIMA, M., IMAZAWA, T., TAKAMURA, T., TAKAHASHI, M. AND HAYASHI, Y.: Promoting effect of metal compounds on liver, stomach, kidney, pancreas and skin carcinogenesis. J. Am. Coll. Toxicol. 8: 1235-1239, 1989.
27. LEOPOLD, W. R., MILLER, E. C. AND MILLER, J. A.: Carcinogenicity of antitumor cis-platinum (II) coordination complexes in the mouse and rat. Cancer Res. 39: 913-918, 1979.
28. LEYSHON-SORLAND, K., MORKRID, L. AND RUGSTAD, H. E.. Metallothionein: A protein conferring resistance in vitro to tumor necrosis factor. Cancer Res. 53: 4874-4880, 1993.
29. LIU, J., KERSHAW, W. C. AND KLAASSEN, C. D.: Rat primary hepatocyte cultures are a good model for examining metallothionein-induced tolerance to cadmium toxicity. In Vitro Cell. Dev. Biol. 26: 75-79, 1990.
30. NAGANUMA, A., SATOH, M., KOYAMA, Y. AND IMUKA, N.: Protective effect of metallothionein-inducing metals on the lethal toxicity of cis-diamminedichloroplatinum in mice. Toxicol. Lett. 24: 203-207, 1985.
31. NARTEY, N., CHERLAN, M. G. AND BANERJEE, D.: Immunohistochemical localization of metallothionein in human thyroid tumors. Am. J. Pathol. 129: 177-182, 1987.
32. 2 on Dunn osteosarcoma. Nippon Seikeigeka Gakkai Zasshi 64: 70-75, 1990.
33. SCHROEDER, H. A., BALASSA, J J. AND VINTON, W. H.. Chromium, lead, cadmium, nickel and titanium in mice; effect on mortality, tumors and tissue levels. J. Nutr. 83: 239-250, 1964.
34. SCIAVOLINO, P. J., LEE, T. A. AND VILCEK, J.: Overexpression of metallothionein confers resistance to the cytotoxic effect of TNF with cadmium in MCF-7 breast carcinoma cells. Lymphokine Cytokine Res. 11: 265-270, 1992.
35. SHIRAISHI, N., HOCHADEL, J. F., COOGAN, T. P., KOROPATNICK, J. AND WAALKES, M. P.: Cadmium-induced genotoxicity in the absence of cytotoxicity in rat testicular cells is associated with minimal activity of the metallothionein gene. Toxicol. Appl. Pharmacol. 130: 229-236, 1995.
36. SINGH, G. AND KOROPATNICK, J.: Differential toxicity of cis and trans isomers of dichlorodiammineplatinum. J. Biochem. Toxicol. 3: 223-233, 1988.
37. STACEY, N. H., CANTILENA, L. R. AND KLAASSEN, C. D.: Cadmium toxicity and lipid peroxidation in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 53: 470-480, 1980.
38. WAALKES, M. P.: Metal Carcinogenesis. In Metal Toxicology, ed. by R. A. Goyer, C. D. Klaassen, and M. P. Waalkes, pp. 47-69, Academic Press, San Diego, CA, 1995.
39. WAALKES, M. P. AND GOERING, P. L.: Metallothionein and other cadmium-binding proteins. Recent developments. Chem. Res. Toxicol. 3: 281-288, 1990.
40. WAALKES, M. P., REHM, S., RIGGS, C. W., BARE, R. M., DEVOR, D. E., POIRIER, L. A., WENK, M. L., HENNEMAN, J. R. AND BALASCHAK, M. S.: Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: Dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res. 48: 4656-4663, 1988a.
41. WAALKES, M. P., MILLER, M. S., WILSON, M. J., BARE, R. M. AND MCDOWELL, A. E : Increased metallothionein gene expression in 5-aza-2′-deoxycytidine-induced resistance to cadmium cytotoxicity. Chem.-Biol. Interact. 66: 189-204, 1988b.
42. WAALKES, M. P., DIWAN, B. A., BARE, R. M., WARD, J. M., WEGHORST, C. AND RICE, J. M.: Anticarcinogenic effects of cadmium in B6C3F1 mouse liver and lung. Toxicol. Appl. Pharmacol. 110: 327-335, 1991.
43. WAALKES, M. P., DIWAN, B. A., WEGHORST, C. M., WARD, J. M., RICE, J. M., CHERIAN, M. G. AND GOYER, R. A.: Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung: Late stage vulnerability of tumors to cadmium and the role of metallothionein. J. Pharmacol. Exp. Ther. 266: 1656-1663, 1993.
44. WAALKES, M. P.: Medical implications of metallothionein. In Metallothionein III, ed. by K. T. Suzuki, N. Imura, and M. Kimura, pp. 303-316, Birkhäuser Verlag, Basel, Switzerland, 1993.
45. WARD, J. M., RICE, J. M., CREASIA, D., LYNCH, P. AND RIGGS, C.: Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis 4: 1021-1029, 1983.